Alpha-adrenergic receptor subtypes.
D000818:Animals; D001667:Binding, Competitive; D003000:Clonidine / Q000378:metabolism / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D066298:In Vitro Techniques; D008954:Models, Biological; D009638:Norepinephrine / Q000378:metabolism; D010646:Phentolamine / Q000494:pharmacology / Q000627:therapeutic use; D011224:Prazosin / Q000494:pharmacology / Q000627:therapeutic use; D011869:Radioligand Assay; D011941:Receptors, Adrenergic / Q000032:analysis*; D011942:Receptors, Adrenergic, alpha / Q000032:analysis* / Q000187:drug effects / Q000502:physiology; D015016:Yohimbine / Q000494:pharmacology / Q000627:therapeutic use
D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D004088:Dihydroergotoxine; D015016:Yohimbine; D003000:Clonidine; D009638:Norepinephrine; D011224:Prazosin; D004837:Epinephrine; D010646:Phentolamine